Site Map

ASTRO: Lu-177 PNT2002 added to SBRT delays prostate cancer progression

ASTRO: Contemporary IMRT comparable to proton therapy for throat cancer

NAPT survey results show promise for proton therapy adoption

ASTRO: Low-dose RT effective for treating knee osteoarthritis

ASTRO: Genomic test predicts benefit of hormone therapy in prostate cancer

CPDC launches Cadena Research for radiopharmaceutical development

Polarean enters xenon MRI supply agreement with UVA Health

Minicarm.com named exclusive distributor for Hologic's Fluoroscan

ASTRO: Patient navigation key to mitigating RT treatment disparities

Page 1 of 1